Sun Pharma posted a total income of Rs 6846 crore, a 4 per cent growth.

The drug in question is CEQUA (cyclosporine ophthalmic solution) 0.09 per cent.

The company had reported consolidated profit of Rs 1,471.82 crore in the corresponding quarter of last year.

Performance was affected by a sharp decline in sales of Taro, its US listed subsidiary , pricing pressure in the US market, and the impact ...

Some analysts suggested that investors willing to overlook the subdued outlook.

Sun was tipped into a loss this quarter after it agreed to pay plaintiffs including Canadian rival Apotex to settle a lawsuit over sleep-di...

The pharma major had reported a profit of Rs 2,033.71 crore in the same quarter last year.

IDFC and Shriram Group agreed create the largest retail-focused bank in the country